Table 2.
SNP | rs Number | Group | n | Genotype | p-Value | OR (95% CI) | ||
---|---|---|---|---|---|---|---|---|
AA | AG | GG | ||||||
IL13 A2044 | 20541 | Control | 189 | 0.063 | 0.492 | 0.444 | 1.199 | |
Patients | 189 | 0.115 | 0.396 | 0.490 | 0.78 | (0.801–1.794) | ||
AA | AG | GG | ||||||
ADRB2 R16G | 1042713 | Control | 188 | 0.229 | 0.4840.287 | 1.056 | ||
Patients | 191 | 0.199 | 0.503 | 0.298 | 0.811 | (0.678–1.643) | ||
AA | AG | GG | ||||||
FcER1 E237G | 569108 | Control | 189 | 0.868 | 0.127 | 0.005 | 0.984 | |
Patients | 192 | 0.885 | 0.109 | 0.005 | 0.991 | (0.678–1.643) | ||
CC | CT | TT | ||||||
IL13 C1923T | 1295686 | Control | 186 | 0.414 | 0.516 | 0.07 | 2.119 | |
Patients | 182 | 0.429 | 0.434 | 0.137 | 0.033 | (0.678–1.643) | ||
CC | CT | TT | ||||||
FcER1 C-109T | 1441586 | Control | 188 | 0.351 | 0.463 | 0.186 | 0.994 | |
Patients | 189 | 0.291 | 0.524 | 0.185 | 0.78 | (0.591–1.67) | ||
CC | CT | TT | ||||||
IL13 C-1112T | 1800925 | Control | 187 | 0.594 | 0.369 | 0.037 | 1.13 | |
Patients | 190 | 0.632 | 0.326 | 0.042 | 0.816 | (0.401–3.182) | ||
AA | AG | GG | ||||||
IL4RA Q551R | 1801275 | Control | 189 | 0.593 | 0.365 | 0.042 | 0.865 | |
Patients | 190 | 0.521 | 0.442 | 0.037 | 0.784 | (0.307–2.436) | ||
AA | AG | GG | ||||||
IL4RA I75V | 1805010 | Control | 188 | 0.340 | 0.473 | 0.186 | 1.056 | |
Patients | 191 | 0.328 | 0.425 | 0.247 | 0.151 | (0.678–1.643) | ||
CC | CT | TT | ||||||
IL4 C-590T | 2243250 | Control | 189 | 0.667 | 0.259 | 0.074 | 1.471 | |
Patients | 190 | 0.542 | 0.353 | 0.105 | 0.288 | (0.72–3.006) | ||
CC | CT | TT | ||||||
CHI3L1 C-131G 4950928 | Control | 189 | 0.64 | 0.333 | 0.026 | 1.187 | ||
Patients | 192 | 0.635 | 0.333 | 0.031 | 0.78 | (0.356–3.958) |
rs, reference SNP; OR, odds ratio; CI, confidence interval.